FLEXXICON DIALYSIS CATHETER KIT 11F X 20CM (SHORT-TERM) (DUAL-LUMEN) N/A 5678200

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a company representative report with the FDA on 2018-12-21 for FLEXXICON DIALYSIS CATHETER KIT 11F X 20CM (SHORT-TERM) (DUAL-LUMEN) N/A 5678200 manufactured by Bard Access Systems.

Event Text Entries

[131191682] The following were reviewed as part of this investigation: patient severity, frequency analysis, applicable previous investigation(s), sample (if available), applicable fmea documents, labeling, and applicable manufacture records. Based on a review of this information, the following was concluded: the complaint that the guidewire became stuck in the introducer needle was confirmed and the damage appeared to be related to use of the device. One 0. 038? Guidewire was received within an 18g introducer needle. The distal tip of the guidewire was lodged in the needle. The guidewire was not extending from the distal tip of the introducer needle. A microscopic examination of the 18g introducer needle revealed that the inner edge of the opening at the needle bevel was deformed. Blood residue was visible within the needle. It was noted that the core wire broke at the distal weld tip, which allowed the coil wire to stretch over the core wire. The guidewire was forcefully pulled from the introducer needle. Biological material was found on the section of coil wire that was within the introducer needle. The damage at the needle bevel and the presence of biological residue lodged between the guidewire and needle indicate that the guidewire was retracted within the introducer needle. The outside diameter (od) of the guidewire was found to be within specification. The product ifu cautions,? Do not pull back guidewire over needle bevel as this may sever the end of the guidewire. The introducer needle must be removed first. Also, if unusual resistance is met during manipulation of the guidewire, discontinue the procedure and determine the cause of resistance before proceeding. Withdraw needle and guidewire if cause of resistance cannot be determined.? A lot history review (lhr) of recr1630 showed one other similar product complaint(s) from this lot number.
Patient Sequence No: 1, Text Type: N, H10


[131191683] The guidewire stuck with the needle while insertion (inside the needle). On (b)(6) 2018, per sample evaluation, the core wire broke at the distal weld tip.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3006260740-2018-03648
MDR Report Key8189400
Report SourceCOMPANY REPRESENTATIVE
Date Received2018-12-21
Date of Report2018-12-20
Date of Event2018-10-18
Date Mfgr Received2018-12-04
Device Manufacturer Date2018-04-01
Date Added to Maude2018-12-21
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactKELSEY ERICKSON
Manufacturer Street605 N. 5600 W.
Manufacturer CitySALT LAKE CITY UT 84116
Manufacturer CountryUS
Manufacturer Postal84116
Manufacturer Phone8015225937
Manufacturer G1BARD REYNOSA S.A. DE C.V. -9617592
Manufacturer StreetBLVD. MONTEBELLO #1 PARQUE INDUSTRIAL COLONIAL
Manufacturer CityREYNOSA, TAMAULIPAS
Manufacturer CountryMX
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameFLEXXICON DIALYSIS CATHETER KIT 11F X 20CM (SHORT-TERM) (DUAL-LUMEN)
Generic NameCATHETER, SUBCLAVIAN
Product CodeLFJ
Date Received2018-12-21
Returned To Mfg2018-11-21
Model NumberN/A
Catalog Number5678200
Lot NumberRECR1630
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerBARD ACCESS SYSTEMS
Manufacturer Address605 N. 5600 W. SALT LAKE CITY UT 84116 US 84116


Patients

Patient NumberTreatmentOutcomeDate
10 2018-12-21

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.